Why Choose Allo Chassis™?

Allo Chassis™ is ideal for innovators pursuing ready-made HLA-null iPSCs cell lines for the development of allogeneic cell therapies. Cellistic cell lines manufactured under GMP principles and using proprietary IP allow for a broad range of applications – in regenerative medicine, immune-evasive CAR-T and NK cell therapies, tissue engineering and organ transplantation – with the certainty that the product is compliant all the way to commercialization.

GMP Ready
Manufactured based on cGMP principles in Cellistic's state-of-the-art, EMA-approved facility.

Fast-Track Development
Save the time sourcing primary cells, reprograming and editing by directly using our immune-cloaked cell lines.

Clear Cost Structure
Costs and license fees are defined through commercialization.

Leverage iPSC know-how and IP
Our Allo Chassis™ is created by a team that has developed numerous iPSC cell lines and edited using our proprietary STAR-CRISPR™ technology. 

What You Get with Allo Chassis™

When you put Allo Chassis™ to work, you get a complete solution designed to minimize complexity and maximize value. And you get it delivered by an experienced, multidisciplinary team housed in Europe’s first facility exclusively dedicated to iPSC-based allogeneic cell therapy manufacturing.
CELL-Allo Chassis Webpage Images-01
Ready-to-Use iPSC Cell Lines

High-quality, immune-cloaked lines available for immediate use and customization.

CELL-Allo Chassis Webpage Images-05
IP Licensing

Clear, flexible licensing for commercialization of Allo Chassis™ technology.

CELL-Allo Chassis Webpage Images-03
GMP Documentation

Comprehensive documentation to support your IND application process.

CELL-Allo Chassis Webpage Images-04
Differentiation Capabilities

 Summary of the differentiation capabilities of the customer Allo Chassis™ cell lines.

CELL-Allo Chassis Webpage Images-02
Support for Gene Editing & Development

Tailor cell lines to meet the needs of your specific therapy.

Allo Chassis Fact Sheet

Discover how Allo Chassis™ can support your allogeneic cell therapy development—download the fact sheets to learn more. 

How is it made? The Science Behind Allo Chassis™

Allo Chassis™ is powered by advanced gene-editing technologies and automation, ensuring high-quality, scalable solutions for your cell therapy development. 
Group 55

Immune
Cloaking

Expertly engineered strategies to minimize immune recognition and enhance compatibility.

Learn More

Cell Line Development Automation

Built using automated processes, Allo ChassisTM integrates scalable workflows that deliver consistent, reliable results.

Learn More

STAR-CRISPR™ Technology

Our STAR-CRISPR™ gene-editing technology ensures precision and reproducibility, with strong IP protection and clear licensing terms.

Learn More
Copy of CELL-23-015-Icon-7

Quality Control Strategy

We implement rigorous quality assurance processes at every stage, ensuring consistent, precise results that meet the highest standards. Our commitment to accuracy and reliability means you can trust our work to deliver dependable outcomes every time.

Learn More

GMP Considerations for iPSC cell lines

Allo ChassisTM is developed following current Good Manufacturing Practice (cGMP) standards, with rigorous quality control and validation for optimal cell line quality and low passage numbers.



Learn More

Get in the Driver’s Seat with Allo Chassis™

Ready to move your cell therapy development forward, faster? Contact us today! Our team will reach out to you within 24h.

Next steps:
  • Schedule a call to discuss your project
  • Receive a customized quote
  • Get your ready-to-use iPSC cell lines & advance your cell therapy application!

Connect with us